Sana Biotechnology is a biotechnology company that develops and delivers engineered cells as medicines for patients. The company's platform allows for the rapid development of cell-based therapies that can be delivered directly to patients. Sana Biotechnology is focused on developing treatments for a range of diseases, including cancer, genetic disorders, and infectious diseases. The company was founded in 2018 by a group of experienced biotech executives and is headquartered in Seattle, Washington.